Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Cohen

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|November 16, 2024
PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysisYang Wang, Sen Hong, Hannah Hudson, et al.
The Journal of Biological Chemistry|September 24, 2005
The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pitsRita Garuti, Christopher Jones, Wei-Ping Li, et al.
The Journal of Clinical Investigation|September 5, 2002
Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterolLiqing Yu, Jia Li-Hawkins, Robert E Hammer, et al.
Human Mutation|April 23, 2002
Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC)Ralph V Shohet, Gloria L Vega, Thomas P Bersot, et al.
The Journal of Clinical Investigation|April 21, 2005
Lack of MEF2A mutations in coronary artery diseaseLi Weng, Nihan Kavaslar, Anna Ustaszewska, et al.
Hepatology (Baltimore, Md.)|June 12, 2014
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosisEriks Smagris, Soumik BasuRay, John Li, et al.
The Journal of Biological Chemistry|December 26, 2009
A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysisShaoqing He, Christopher McPhaul, John Zhong Li, et al.
The Journal of Biological Chemistry|April 25, 2007
Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradationDa-Wei Zhang, Thomas A Lagace, Rita Garuti, et al.
Nature Genetics|September 30, 2008
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseStefano Romeo, Julia Kozlitina, Chao Xing, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicityJeffrey D Browning, Lidia S Szczepaniak, Robert Dobbins, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|November 16, 2024
PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysisYang Wang, Sen Hong, Hannah Hudson, et al.
The Journal of Biological Chemistry|September 24, 2005
The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pitsRita Garuti, Christopher Jones, Wei-Ping Li, et al.
The Journal of Clinical Investigation|September 5, 2002
Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterolLiqing Yu, Jia Li-Hawkins, Robert E Hammer, et al.
Human Mutation|April 23, 2002
Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC)Ralph V Shohet, Gloria L Vega, Thomas P Bersot, et al.
The Journal of Clinical Investigation|April 21, 2005
Lack of MEF2A mutations in coronary artery diseaseLi Weng, Nihan Kavaslar, Anna Ustaszewska, et al.
Hepatology (Baltimore, Md.)|June 12, 2014
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosisEriks Smagris, Soumik BasuRay, John Li, et al.
The Journal of Biological Chemistry|December 26, 2009
A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysisShaoqing He, Christopher McPhaul, John Zhong Li, et al.
The Journal of Biological Chemistry|April 25, 2007
Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradationDa-Wei Zhang, Thomas A Lagace, Rita Garuti, et al.
Nature Genetics|September 30, 2008
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseStefano Romeo, Julia Kozlitina, Chao Xing, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicityJeffrey D Browning, Lidia S Szczepaniak, Robert Dobbins, et al.
Pageof 12